Cerus Corporation

Financials

Totale attivo 200.92 M206.78 M213.07 M215.19 M221.86 M Totale passività 144.02 M150.53 M156.9 M152.98 M156.89 M Patrimonio netto totale 56.9 M56.24 M56.17 M62.2 M64.97 M Totale passività e patrimonio netto 200.92 M206.78 M213.07 M215.19 M221.86 M Debito totale 84.16 M84.97 M84.89 M84.9 M83.89 M Indebitamento netto 3.71 M4.05 M6.87 M6.39 M1.01 M

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

CERS

Financials

Cerus Corporation

Notizie

Jensen, chief legal officer di Cerus Corp, vende azioni per 187k$

Jensen, Cerus Corp chief legal officer, sells $187k in stock

Il CEO di Cerus Corp Greenman vende azioni per 742.000$

Il COO di Cerus Corp Jayaraman vende azioni per 273.000 dollari

Cerus Corp: il chief medical officer Benjamin vende azioni per 168k$

Il CFO di Cerus Corp Green vende azioni per 211.000 dollari

Cerus Corp COO Jayaraman sells $273k in shares

Cerus Corp CEO Greenman sells $742k in shares

Cerus Corp: chief medical officer Benjamin sells $168k in shares

Cerus Corp CFO green sells $211k in shares

Cerus names COO Vivek Jayaraman as next CEO effective July 1

Il CFO di Cerus Kevin Green vende azioni per 169.000$